April 2024 - Integrated care, wellbeing economics and cancer medicines

Welcome to the fourth episode of Health Econ On The Go. In this episode, we will cover three papers from March 2024, discussing financial incentives for integrated care, wellbeing improvements as a novel outcome measure in health, and the rising costs of oncology drugs in Canada. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at healthecononthego@gmail.com

Papers discussed on this episode:

“A QALY is [still] a QALY is [still] a QALY?” available here: https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-024-01036-w “Financial incentives for integrated care: A scoping review and lessons for evidence-based design” available here: https://pubmed.ncbi.nlm.nih.gov/38290390/ “From Health to Wellbeing: Toward a Monetary Valuation of a Wellbeing-Adjusted Life-Year“ available here: https://www.valueinhealthjournal.com/article/S1098-3015(24)00087-1/fulltext” “Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada: a cross-sectional study“ available here: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00072-X/abstract

Sedated: How Modern Capitalism Created our Mental Health Crisis – Book review available here: https://www.goodreads.com/en/book/show/57751566